4//SEC Filing
Pernock David 4
Accession 0001209191-19-005445
CIK 0000827871other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:05 PM ET
Size
9.4 KB
Accession
0001209191-19-005445
Insider Transaction Report
Form 4
Pernock David
Director
Transactions
- Tax Payment
Common Stock
2019-01-07$41.33/sh−858$35,461→ 10,108 total - Award
Common Stock
2019-01-23+20,900→ 31,008 total - Award
Employee Stock Option (right to buy)
2019-01-23+46,600→ 46,600 totalExercise: $42.40Exp: 2029-01-23→ Common Stock (46,600 underlying)
Footnotes (4)
- [F1]Represents shares withheld to satisfy withholding tax obligations.
- [F2]Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 23, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 23, 2020, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001471956
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 8:05 PM ET
- Size
- 9.4 KB